Market Leadership STRATEC's established reputation as a leading provider of automation solutions for in-vitro diagnostics offers significant opportunities to partner with healthcare providers and biotech firms seeking reliable, high-quality laboratory automation systems.

Product Diversification Recent launches of stand-alone modules and chemiluminescence immunoassay platforms indicate an expanding product portfolio, creating potential sales avenues within diagnostics companies looking to enhance or diversify their offerings.

Strategic Acquisitions The acquisition of Natech Plastics and Sony DADC BioSciences demonstrates STRATEC’s focus on expanding both its technological capabilities and geographic footprint, opening doors to new customer segments and markets, especially in the US.

Innovation Focus Building on over forty years of expertise, STRATEC’s continuous development of advanced automation and consumable solutions positions it as a key partner for companies investing in cutting-edge diagnostics technology.

Financial Growth Potential With a revenue between $10 million and $25 million and ongoing strategic expansions, STRATEC presents an attractive sales opportunity for partners aiming to collaborate with innovative companies poised for growth in the rapidly evolving medical equipment sector.